Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
In recent years, several associations between common chronic human disorders and altered gut microbiome composition and function have been reported. In most of these reports, treatment regimens were not controlled for and conclusions could thus be confounded by the effects of various drugs on the microbiota, which may obscure microbial causes, protective factors or diagnostically relevant signals. Our study addresses disease and drug signatures in the human gut microbiome of type 2 diabetes mellitus (T2D). Two previous quantitative gut metagenomics studies of T2D patients that were unstratified for treatment yielded divergent conclusions regarding its associated gut microbial dysbiosis. Here we show, using 784 available human gut metagenomes, how antidiabetic medication confounds these results, and analyse in detail the effects of the most widely used antidiabetic drug metformin. We provide support for microbial mediation of the therapeutic effects of metformin through short-chain fatty acid production, as well as for potential microbiota-mediated mechanisms behind known intestinal adverse effects in the form of a relative increase in abundance of Escherichia species. Controlling for metformin treatment, we report a unified signature of gut microbiome shifts in T2D with a depletion of butyrate-producing taxa. These in turn cause functional microbiome shifts, in part alleviated by metformin-induced changes. Overall, the present study emphasizes the need to disentangle gut microbiota signatures of specific human diseases from those of medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“patient treatment with the drug metformin, a variable that subjects had not been stratified for previously, constituted the main determinant of microbial signatures in diabetic cohorts [62].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [62]
In the citing paper
“This action is an important determinant for the anti-hyperglycemic therapeutic effects, the gastrointestinal side effects and possibly the anti-aging effects of metformin (88, 89).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [88]
In the citing paper
“As for C. elegans, metformin use in humans will change the microbiome.”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [88]
In the citing paper
“Studies comparing individuals with T2D treated or not with metformin identified a higher level of E. coli and a lower level of Intestinibacter in the metformin-treated individuals, while confirming reduced levels of butyrate-producing bacteria such as Roseburia spp., F. prausnitzii, and unnamed Clostridiales in the untreated individuals compared to healthy controls5, 6, 34, 35.”
From The gut microbiome in atherosclerotic cardiovascular disease (2017) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glöckner, F. O. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1219 · Cited by 33,055
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
UPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
FLASH: fast length adjustment of short reads to improve genome assemblies
Magoč, T., & Salzberg, S. L. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr507 · Cited by 15,366
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Li, W., & Godzik, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl158 · Cited by 11,410
VEGAN, a package of R functions for community ecology
Dixon, P. (2003) · Journal of Vegetation Science · doi:10.1111/j.1654-1103.2003.tb02228.x · Cited by 6,824
Cited by
Items 301–400 of 1,006
Gut Microbiome Profiles Are Associated With Type 2 Diabetes in Urban Africans
Doumatey, A. P., Adeyemo, A., Zhou, J., Lei, L., Adebamowo, S. N., Adebamowo, C., & Rotimi, C. N. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00063 · Cited by 159
The Ocular Microbiome: Molecular Characterisation of a Unique and Low Microbial Environment
Ozkan, J., & Willcox, M. D. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1570526 · Cited by 159
Gormsen, L. C., Sundelin, E. I., Jensen, J. B., Vendelbo, M. H., Jakobsen, S., Munk, O. L., Hougaard Christensen, M. M., Brøsen, K., Frøkiær, J., & Jessen, N. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.177774 · Cited by 143
van Stee, M. F., de Graaf, A. A., & Groen, A. K. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0738-4 · Cited by 145
Palacios, T., Vitetta, L., Coulson, S., Madigan, C. D., Lam, Y. Y., Manuel, R., Briskey, D. R., Hendy, C., Kim, J.-N., Ishoey, T., et al. (2020) · Nutrients · doi:10.3390/nu12072041 · Cited by 159
Kunisada, Y., Eikawa, S., Tomonobu, N., Domae, S., Uehara, T., Hori, S., Furusawa, Y., Hase, K., Sasaki, A., & Udono, H. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.10.009 · Cited by 149
Huart, J., Leenders, J., Taminiau, B., Descy, J., Saint‐Remy, A., Daube, G., Krzesinski, J.-M., Melin, P., Tullio, P. D., & Jouret, F. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12588 · Cited by 158
Safarchi, A., Al-Qadami, G. H., Tran, C. D., & Conlon, M. A. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1559521 · Cited by 158
Metformin; a review of its history and future: from lilac to longevity: THOMAS AND GREGG
Thomas, I., & Gregg, B. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12473 · Cited by 140
Gaike, A. H., Paul, D., Bhute, S. S., Dhotre, D. P., Pande, P., Upadhyaya, S., Reddy, Y. B. S., Sampath, R., Ghosh, D., Chandraprabha, D., et al. (2020) · mSystems · doi:10.1128/msystems.00578-19 · Cited by 156
Ahmadi, S., Razazan, A., Nagpal, R., Jain, S., Wang, B., Mishra, S. P., Wang, S., Justice, J., Ding, J., McClain, D. A., et al. (2020) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glaa056 · Cited by 145
The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis
Hasani, A., Ebrahimzadeh, S., Hemmati, F., Khabbaz, A., Hasani, A., & Gholizadeh, P. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001435 · Cited by 152
Zhang, J., Zhang, F., Zhao, C., Xu, Q., Liang, C., Yang, Y., Wang, H., Shang, Y., Wang, Y., Mu, X., et al. (2018) · Endocrine · doi:10.1007/s12020-018-1831-x · Cited by 152
Oral selective serotonin reuptake inhibitors activate vagus nerve dependent gut-brain signalling
McVey Neufeld, K.-A., Bienenstock, J., Bharwani, A., Champagne-Jorgensen, K., Mao, Y., West, C., Liu, Y., Surette, M. G., Kunze, W., & Forsythe, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-50807-8 · Cited by 132
Friedman, E. S., Li, Y., Shen, T.-C. D., Jiang, J., Chau, L., Adorini, L., Babakhani, F., Edwards, J., Shapiro, D., Zhao, C., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.022 · Cited by 149
Gut microbiota and obesity: Concepts relevant to clinical care
Dao, M. C., & Clément, K. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.10.005 · Cited by 151
Alcohol’s Impact on the Gut and Liver
Pohl, K., Moodley, P., & Dhanda, A. (2021) · Nutrients · doi:10.3390/nu13093170 · Cited by 149
Genomics and metagenomics of trimethylamine-utilizing Archaea in the human gut microbiome
Borrel, G., McCann, A., Deane, J., Neto, M. C., Lynch, D. B., Brugère, J. F., & O’Toole, P. W. (2017) · The ISME Journal · doi:10.1038/ismej.2017.72 · Cited by 135
Association of metformin administration with gut microbiome dysbiosis in healthy volunteers
Elbere, I., Kalnina, I., Silamikelis, I., Konrade, I., Zaharenko, L., Sekace, K., Radovica-Spalvina, I., Fridmanis, D., Gudra, D., Pirags, V., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204317 · Cited by 134
Willers, M., Ulas, T., Völlger, L., Vogl, T., Heinemann, A. S., Pirr, S., Pagel, J., Fehlhaber, B., Halle, O., Schöning, J., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.019 · Cited by 145
Gut Microbiome Toxicity: Connecting the Environment and Gut Microbiome-Associated Diseases
Tu, P., Chi, L., Bodnar, W. M., Zhang, Z., Gao, B., Bian, X., Stewart, J. R., Fry, R. C., & Lü, K. (2020) · Toxics · doi:10.3390/toxics8010019 · Cited by 146
Ruuskanen, M. O., Erawijantari, P. P., Havulinna, A. S., Liu, Y., Méric, G., Tuomilehto, J., Inouye, M., Jousilahti, P., Salomaa, V., Jain, M., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2358 · Cited by 128
The Gut Microbiome in Pancreatic Disease
Akshintala, V. S., Talukdar, R., Singh, V. K., & Goggins, M. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.045 · Cited by 131
DeFronzo, R. A., Buse, J. B., Kim, T., Burns, C., Skare, S., Baron, A., & Fineman, M. (2016) · Diabetologia · doi:10.1007/s00125-016-3992-6 · Cited by 128
Cai, W., Xu, J., Li, G., Liu, T., Guo, X., Wang, H., & Luo, L. (2019) · Food Research International · doi:10.1016/j.foodres.2019.108939 · Cited by 145
Akkermansia muciniphila: a novel functional microbe with probiotic properties
Gómez-Gallego, C., Pohl, S., Salminen, S., De Vos, W. M., & Kneifel, W. (2016) · Beneficial Microbes · doi:10.3920/bm2016.0009 · Cited by 130
Community profiling of the urinary microbiota: considerations for low-biomass samples
Karstens, L., Asquith, M. J., Caruso, V. G., Rosenbaum, J. T., Fair, D. A., Braun, J. G., Gregory, W. T., Nardos, R., & McWeeney, S. K. (2018) · Nature Reviews Urology · doi:10.1038/s41585-018-0104-z · Cited by 142
Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes
Menni, C., Zhu, J., Le Roy, C. I., Mompeo, O., Young, K., Rebholz, C. M., Selvin, E., North, K. E., Mohney, R. P., Bell, J. T., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1778261 · Cited by 126
Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes
Huda, M. N., Kim, M., & Bennett, B. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632335 · Cited by 142
Mei, Z., Wang, F., Bhosle, A., Dong, D., Mehta, R. S., Ghazi, A. R., Zhang, Y., Liu, Y., Rinott, E., Ma, S., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03067-7 · Cited by 143
Precancer Atlas to Drive Precision Prevention Trials
Spira, A., Yurgelun, M. B., Alexandrov, L., Rao, A., Bejar, R., Polyak, K., Giannakis, M., Shilatifard, A., Finn, O. J., Dhodapkar, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2346 · Cited by 129
Gut microbiota and old age: Modulating factors and interventions for healthy longevity
Coman, V., & Vodnar, D. C. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111095 · Cited by 118
The role of the gut microbiota in health and cardiovascular diseases
Wang, L., Wang, S., Zhang, Q., He, C., Fu, C., & Wei, Q. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00091-2 · Cited by 122
The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
Chakaroun, R., Olsson, L. M., & Bäckhed, F. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00771-0 · Cited by 139
Metformin and gut microbiota: their interactions and their impact on diabetes
Vallianou, N. G., Stratigou, T., & Tsagarakis, S. (2019) · Hormones · doi:10.1007/s42000-019-00093-w · Cited by 138
Gut microbiota and type 2 diabetes mellitus
Muñoz‐Garach, A., Díaz-Perdigones, C. M., & Tinahones, F. J. (2016) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2016.07.004 · Cited by 139
Salamon, D., Sroka-Oleksiak, A., Kapusta, P., Szopa, M., Mrozińska, S., Ludwig‐Słomczyńska, A. H., Wołkow, P. P., Bulanda, M., Klupa, T., Malecki, M. T., et al. (2018) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.4246 · Cited by 140
Metformin: old friend, new ways of action–implication of the gut microbiome?
Rodriguez, J., Hiel, S., & Delzenne, N. M. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000468 · Cited by 136
Gut Microbiome in Obesity, Metabolic Syndrome, and Diabetes
Chen, X., & Devaraj, S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1104-3 · Cited by 136
Bi-directional drug-microbiome interactions of anti-diabetics
Whang, A., Nagpal, R., & Yadav, H. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.046 · Cited by 137
Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes
Arora, T., & Tremaroli, V. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.761834 · Cited by 136
Jo, J.-H., Harkins, C. P., Schwardt, N. H., Portillo, J. A., Program, N. C. S., Zimmerman, M. D., Carter, C. L., Hossen, M. A., Peer, C. J., Polley, E. C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd8077 · Cited by 116
Effects of Antidiabetic Drugs on Gut Microbiota Composition
Montandon, S., & Jornayvaz, F. (2017) · Genes · doi:10.3390/genes8100250 · Cited by 135
Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment
Li, M., Li, X., Zhang, H., & Lü, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01039 · Cited by 135
Deng, J., Zeng, L., Lai, X., Li, J., Liu, L., Lin, Q., & Chen, Y. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13342 · Cited by 135
Self-citationAn overview of cancer health disparities: new approaches and insights and why they matter
Minas, T. Z., Kiely, M., Ajao, A., & Ambs, S. (2021) · Carcinogenesis · doi:10.1093/carcin/bgaa121 · Cited by 115
Shukla, V., Singh, S., Verma, S., Verma, S., Rizvi, A. A., & Abbas, M. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.08.005 · Cited by 133
Pedersen, C., Gallagher, E., Horton, F., Ellis, R. J., Ijaz, U. Z., Wu, H., Jaiyeola, E., Diribe, O., Duparc, T., Cani, P. D., et al. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516004086 · Cited by 117
Exploring the oral-gut linkage: Interrelationship between oral and systemic diseases
Yamazaki, K., & Kamada, N. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.11.006 · Cited by 134
Szopinska-Tokov, J., Dam, S., Naaijen, J., Konstanti, P., Rommelse, N., Belzer, C., Buitelaar, J., Franke, B., Bloemendaal, M., Aarts, E., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8030406 · Cited by 113
Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease
Xie, C., Huang, W., Young, R. L., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2021) · Nutrients · doi:10.3390/nu13041104 · Cited by 132
Effects of anti-aging interventions on intestinal microbiota
Du, Y., Gao, Y., Zeng, B., Fan, X., Yang, D., & Yang, M. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1994835 · Cited by 130
Alexander, S. M., Retnakumar, R. J., Chouhan, D., Devi, T. N. B., Dharmaseelan, S., Devadas, K., Thapa, N., Tamang, J. P., Lamtha, S. C., & Chattopadhyay, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.713955 · Cited by 130
Shin, J., Noh, J., Choe, D., Lee, N., Song, Y., Cho, S., Kang, E., Go, M., Ha, S. K., Chang, D., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01189-5 · Cited by 129
Effects of metformin on the gut microbiota: A systematic review
Petakh, P., Kamyshna, I., & Kamyshnyi, A. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101805 · Cited by 97
Röytiö, H., Mokkala, K., Vahlberg, T., & Laitinen, K. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517002100 · Cited by 128
Inflammatory Bowel Diseases Increase Risk of Type 2 Diabetes in a Nationwide Cohort Study
Jess, T., Jensen, B. W., Andersson, M., Villumsen, M., & Allin, K. H. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.052 · Cited by 112
Liu, Y., Wang, C., Li, J., Li, T., Zhang, Y., Liang, Y., & Mei, Y. (2019) · The FASEB Journal · doi:10.1096/fj.201901943rr · Cited by 128
Self-citationTsunoda, S. M., Gonzales, C., Jarmusch, A. K., Momper, J. D., & JOSEPH, D. R. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-021-01032-y · Cited by 129
Spichak, S., Bastiaanssen, T. F. S., Berding, K., Vlckova, K., Clarke, G., Dinan, T. G., & Cryan, J. F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.044 · Cited by 127
Pedersen, H., Forslund, S. K., Guðmundsdóttir, V., Petersen, A. Ø., Hildebrand, F., Hyötyläinen, T., Nielsen, T., Hansen, T. F., Bork, P., Ehrlich, S. D., et al. (2018) · Nature Protocols · doi:10.1038/s41596-018-0064-z · Cited by 128
Self-citationTowards a mechanistic understanding of reciprocal drug–microbiome interactions
Zimmermann, M., Patil, K. R., Typas, A., & Maier, L. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010116 · Cited by 121
A systematic review on gut microbiota in type 2 diabetes mellitus
Chong, S., Lin, M., Chong, D., Jensen, S. O., & Lau, N. S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1486793 · Cited by 127
Strain-level dissection of the contribution of the gut microbiome to human metabolic disease
Zhang, C., & Zhao, L. (2016) · Genome Medicine · doi:10.1186/s13073-016-0304-1 · Cited by 123
Bajaj, J. S., Idilman, R., Mabudian, L., Hood, M., Fagan, A., Turan, D., White, M. B., Karakaya, F., Wang, J., Atalay, R., et al. (2018) · Hepatology · doi:10.1002/hep.29791 · Cited by 125
Self-citationGut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?
Quigley, E. M. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.29 · Cited by 125
The Gut–Eye Axis: Lessons Learned from Murine Models
Floyd, J. L., & Grant, M. B. (2020) · Ophthalmology and Therapy · doi:10.1007/s40123-020-00278-2 · Cited by 125
Advances in multi-omics study of biomarkers of glycolipid metabolism disorder
Fang, X., Miao, R., Wei, J., Wu, H., & Tian, J. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.10.030 · Cited by 125
Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure
Snelson, M., Muralitharan, R. R., Liu, C., Markó, L., Forslund, S. K., Marques, F. Z., & Tang, W. H. W. (2025) · Circulation Research · doi:10.1161/circresaha.125.325516 · Cited by 126
The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
Aydin, Ö., Nieuwdorp, M., & Gerdes, V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1020-6 · Cited by 124
Wegner, K., Just, S., Gau, L., Henrike, M., Gérard, P., Lepage, P., Clavel, T., & Rohn, S. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-0048-1 · Cited by 124
Gut Microbiota and Host Metabolism: From Proof of Concept to Therapeutic Intervention
Cani, P. D., Moens de Hase, E., & Van Hul, M. (2021) · Microorganisms · doi:10.3390/microorganisms9061302 · Cited by 112
Immunity, microbiota and kidney disease
Knauf, F., Brewer, J. R., & Flavell, R. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0118-7 · Cited by 124
Methods and Reporting Studies Assessing Fecal Microbiota Transplantation: A Systematic Review
Bafeta, A., Yavchitz, A., Riveros, C., Batista, R., & Ravaud, P. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2810 · Cited by 111
Bioactive Dietary Fibers Selectively Promote Gut Microbiota to Exert Antidiabetic Effects
Nie, Q., Hu, J., Gao, H., Li, M., Sun, Y., Chen, H., Zuo, S., Fang, Q., Huang, X., Yin, J., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c01465 · Cited by 122
Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats
Gong, J., Hu, M., Huang, Z., Fang, K., Wang, D., Chen, Q., Li, J., Yang, D., Zou, X., Xu, L., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00042 · Cited by 115
Self-citationPrattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 122
Li, X., Chen, H., He, Y., Chen, W., Chen, J., Gao, L., Hu, H., & Wang, J. (2018) · Molecules · doi:10.3390/molecules23123245 · Cited by 121
Self-citationMcGovern, A. S., Hamlin, A. S., & Winter, G. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419877954 · Cited by 89
Metage2Metabo, microbiota-scale metabolic complementarity for the identification of key species
Belcour, A., Frioux, C., Aïte, M., Bretaudeau, A., Hildebrand, F., & Siegel, A. (2020) · eLife · doi:10.7554/elife.61968 · Cited by 120
Self-citationAkkermansia muciniphila: a potential candidate for ameliorating metabolic diseases
Niu, H., Zhou, M., Zogona, D., Xing, Z., Wu, T., Chen, R., Cui, D., Liang, F., & Xu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1370658 · Cited by 120
Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta‐Analysis
Dujic, T., Zhou, K., Yee, S., van Leeuwen, N., de Keyser, C., Javorský, M., Goswami, S., Zaharenko, L., Hougaard Christensen, M., Out, M., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.567 · Cited by 108
The gut microbiome in Parkinson's disease: A culprit or a bystander?
(2020) · Progress in Brain Research · doi:10.1016/bs.pbr.2020.01.004 · Cited by 103
Cui, J., Ramesh, G., Wu, M., Jensen, E. T., Crago, O. L., Bertoni, A. G., Gao, C., Hoffman, K. L., Sheridan, P. A., Wong, K. E., et al. (2022) · Diabetes · doi:10.2337/db22-0168 · Cited by 119
Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes
Zhu, T., & Goodarzi, M. O. (2020) · Current Nutrition Reports · doi:10.1007/s13668-020-00307-3 · Cited by 118
Roles of the gut microbiome in weight management
Carmody, R. N., & Bisanz, J. E. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00888-0 · Cited by 118
Tran, T. T. T., Cousin, F. J., Lynch, D. B., Menon, R., Brulc, J., Brown, J. R.-M., O’Herlihy, E., Butto, L. F., Power, K., Jeffery, I. B., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0654-1 · Cited by 109
Duan, J., Huang, Y., Tan, X., Chai, T., Wu, J., Zhang, H., Li, Y., Hu, X., Zheng, P., Ji, P., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01428-1 · Cited by 116
Roy, C. I. L., Kurilshikov, A., Leeming, E. R., Visconti, A., Bowyer, R. C. E., Menni, C., Falchi, M., Koutníková, H., Veiga, P., Zhernakova, A., et al. (2022) · BMC Microbiology · doi:10.1186/s12866-021-02364-2 · Cited by 116
Gut microbiota-gonadal axis: the impact of gut microbiota on reproductive functions
Ashonibare, V. J., Akorede, B. A., Ashonibare, P. J., Akhigbe, T. M., & Akhigbe, R. E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1346035 · Cited by 116
Bauer, P. V., Duca, F. A., Waise, T. M. Z., Dranse, H. J., Rasmussen, B. A., Puri, A., Rasti, M., O'Brien, C. A., & Lam, T. K. T. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.013 · Cited by 117
Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective
Valles-Colomer, M., Menni, C., Berry, S. E., Valdes, A. M., Spector, T. D., & Segata, N. (2023) · Nature Medicine · doi:10.1038/s41591-023-02260-4 · Cited by 114
Dao, M. C., Belda, E., Prifti, E., Everard, A., Kayser, B. D., Bouillot, J.-L., Chevallier, J.-M., Pons, N., Le Chatelier, E., Ehrlich, S. D., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00140.2019 · Cited by 92
Self-citationPharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism
Dikeocha, I. J., Al‐Kabsi, A. M., Miftahussurur, M., & Alshawsh, M. A. (2022) · The FASEB Journal · doi:10.1096/fj.202101986r · Cited by 114
Acetate reprograms gut microbiota during alcohol consumption
Martino, C., Zaramela, L. S., Gao, B., Embree, M., Tarasova, J., Parker, S. J., Wang, Y., Chu, H., Chen, P., Lee, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31973-2 · Cited by 115
Annunziata, G., Arnone, A., Ciampaglia, R., Tenore, G. C., & Novellino, E. (2020) · Foods · doi:10.3390/foods9080999 · Cited by 92
The microbiome of the buffalo digestive tract
Feng, T., Wang, T., Gao, N., Liu, Z., Cui, K., Duan, Y., Wu, S., Luo, Y., Li, Z., Yang, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28402-9 · Cited by 115
Zhu, X., Shen, J., Feng, S., Huang, C., Wang, H., Huo, F., & Liu, H. (2023) · Microbiome · doi:10.1186/s40168-023-01567-1 · Cited by 113
Antidiabetic Mechanism of Dietary Polysaccharides Based on Their Gastrointestinal Functions
Hu, J., Nie, S., & Xie, M. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b05410 · Cited by 112
Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
Pellegrino, A., Coppola, G., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Nutrients · doi:10.3390/nu15081815 · Cited by 112
Metadata
- Authors
- MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., Krogh Pedersen, H., Arumugam, M., Kristiansen, K., Yvonne Voigt, A., Vestergaard, H., Hercog, R., Igor Costea, P., Roat Kultima, J., Li, J., Jørgensen, T., Levenez, F., Dore, J., Bjørn Nielsen, H., Brunak, S., Raes, J., Hansen, T., Wang, J., Dusko Ehrlich, S., Bork, P., & Pedersen, O.
- Affiliations
- Vrije Universiteit Brussel (BE)
- University of Copenhagen (DK)
- Rega Institute for Medical Research (BE)
- European Molecular Biology Laboratory (DE)
- Microbiologie de l’alimentation au service de la santé (FR)
- BGI Group (China) (CN)
- Corresponding author
- Pedersen, Oluf
- ORCID
- Venue
- Nature
- Published
- 2015-12-02
- Volume
- 528
- Issue
- 7581
- Pages
- 262-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4681099
- OpenAlex
- W2188930066
- Cited by
- 2,116
- References
- 49
- Citations by year
- 2026: 113 · 2025: 167 · 2024: 212 · 2023: 194 · 2022: 253 · 2021: 270 · 2020: 256 · 2019: 185 · 2018: 197 · 2017: 150 · 2016: 112 · 2015: 3
- FWCI
- 66.83
- Type
- journal article
- Language
- en
- Update notices
- erratum (2017-05-04)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- HAL (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Innovationsfonden
- European Molecular Biology Laboratory
- European Commission (600375, 2007–2013, FP7 2007-2013, HORIZON2020, FP7/2007, 305312, 201052, 261376)
- Agence Nationale de la Recherche (ANR-11-DPBS-0001)
- Lundbeckfonden
- Novo Nordisk
- Göteborgs Universitet
- Copenhagen Graduate School for Nanoscience and Nanotechnology
- Novo Nordisk Foundation Center for Basic Metabolic Research
- H. Lundbeck A/S
- FP7 Ideas: European Research Council (268985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- type 2 diabetes, gut microbiota, metformin, antidiabetic drugs, dysbiosis, confounding by treatment, short-chain fatty acids, butyrate, Escherichia, metagenome-wide association study
- MeSH terms
- Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Male, Metformin, RNA, Ribosomal, 16S, Biodiversity, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.